BOLIGNANO, DAVIDE
 Distribuzione geografica
Continente #
NA - Nord America 4.058
EU - Europa 3.929
AS - Asia 1.820
SA - Sud America 590
AF - Africa 49
Continente sconosciuto - Info sul continente non disponibili 38
Totale 10.484
Nazione #
US - Stati Uniti d'America 3.974
RU - Federazione Russa 2.011
SG - Singapore 755
CN - Cina 576
SE - Svezia 540
BR - Brasile 517
IE - Irlanda 492
DE - Germania 220
HK - Hong Kong 196
FR - Francia 136
UA - Ucraina 124
FI - Finlandia 108
IT - Italia 101
VN - Vietnam 93
GB - Regno Unito 92
IN - India 51
CA - Canada 40
AR - Argentina 29
BD - Bangladesh 24
PL - Polonia 22
JP - Giappone 18
MX - Messico 17
IQ - Iraq 15
TR - Turchia 15
ZA - Sudafrica 15
CZ - Repubblica Ceca 14
ES - Italia 13
ID - Indonesia 12
BE - Belgio 11
MA - Marocco 11
VE - Venezuela 11
AT - Austria 9
CO - Colombia 9
EC - Ecuador 9
NL - Olanda 7
SA - Arabia Saudita 7
AE - Emirati Arabi Uniti 6
LV - Lettonia 6
JM - Giamaica 5
NI - Nicaragua 5
PK - Pakistan 5
TN - Tunisia 5
AZ - Azerbaigian 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
EG - Egitto 4
GY - Guiana 4
HN - Honduras 4
KE - Kenya 4
NP - Nepal 4
OM - Oman 4
UZ - Uzbekistan 4
AL - Albania 3
CH - Svizzera 3
CI - Costa d'Avorio 3
CR - Costa Rica 3
MY - Malesia 3
NO - Norvegia 3
PH - Filippine 3
PS - Palestinian Territory 3
PY - Paraguay 3
SN - Senegal 3
UY - Uruguay 3
BH - Bahrain 2
BN - Brunei Darussalam 2
BO - Bolivia 2
CL - Cile 2
IL - Israele 2
IR - Iran 2
MD - Moldavia 2
TG - Togo 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AO - Angola 1
BG - Bulgaria 1
CY - Cipro 1
DZ - Algeria 1
GE - Georgia 1
GT - Guatemala 1
HU - Ungheria 1
JO - Giordania 1
KG - Kirghizistan 1
KN - Saint Kitts e Nevis 1
KR - Corea 1
KW - Kuwait 1
KY - Cayman, isole 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LT - Lituania 1
ME - Montenegro 1
MN - Mongolia 1
PA - Panama 1
PE - Perù 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
RS - Serbia 1
SI - Slovenia 1
Totale 10.445
Città #
Ashburn 601
Moscow 526
Chandler 499
Dublin 491
Singapore 419
Dallas 329
Jacksonville 282
Nyköping 251
Beijing 223
Hong Kong 196
San Jose 183
The Dalles 122
Council Bluffs 99
Dearborn 90
Los Angeles 86
Princeton 73
Cambridge 69
Lauterbourg 68
Medford 64
Munich 64
New York 62
Des Moines 56
Ann Arbor 50
Boardman 50
Buffalo 34
Ho Chi Minh City 34
São Paulo 34
Santa Clara 31
Helsinki 27
Bremen 25
Frankfurt am Main 25
Lancaster 22
Hanoi 20
San Mateo 20
Tianjin 20
Woodbridge 19
Jinan 18
Orem 17
Seattle 17
Tokyo 17
Atlanta 16
Guangzhou 16
Shanghai 16
Warsaw 16
Wilmington 16
Belo Horizonte 15
Redondo Beach 15
Turku 15
Brooklyn 14
Nanjing 13
Pune 13
Chennai 12
Montreal 12
Brussels 11
Chicago 11
Düsseldorf 11
Houston 11
Brasília 10
Porto Alegre 10
Rio de Janeiro 10
Rome 10
Shenyang 10
Curitiba 9
Denver 9
Haikou 9
Hebei 9
Johannesburg 9
Ningbo 9
Augusta 8
Bexley 8
Boston 8
Brno 8
Dhaka 8
Nanchang 8
Stockholm 8
Falls Church 7
Hyderabad 7
London 7
Tappahannock 7
Washington 7
Baghdad 6
Jiaxing 6
Leawood 6
Manchester 6
Mexico City 6
Recife 6
Riga 6
Toronto 6
Campinas 5
Carapicuíba 5
Charlotte 5
Managua 5
Manaus 5
Norwalk 5
Olomouc 5
Portsmouth 5
San Francisco 5
Shenzhen 5
Zhengzhou 5
Baku 4
Totale 5.868
Nome #
Levels of neutrophil gelatinase-associated lipocalin in 2 patients with crush syndrome after a mudslide. 247
Erythropoietin and its lost receptor. 244
Both IL-1β and TNF-α Regulate NGALExpression in Polymorphonuclear Granulocytes ofChronic Hemodialysis Patients 227
A brief "update" on renal effects of caffeine 219
Preeclampsia and cardiovascular risk: general characteristics, counseling and follow-up. 215
Aquaretic inhibits renal cancer proliferation: Role of vasopressin receptor-2 (V2-R). 212
Dialysis and the Elderly: An Underestimated Problem. 200
Down with the erythropoietin. Long live the erythropoietin! 191
Aquaporin-2 (AQP2) urinary excretion and assumption of water with different mineral content in healthy subjects 187
[Erythropoietin: pleiotropic actions]. 184
Caffeine and the kidney: What evidence right now? 181
A new therapy for kidney injury: regeneration. 180
Antioxidant agents for delaying diabetic kidney disease progression: A systematic review and meta-analysis 179
Acute cardiovascular complications of hemodialysis. 178
Alterations of lipid metabolism in chronic nephropathies: mechanisms, diagnosis and treatment. 175
Effects of haemodialysis on circulating endothelial progenitor cell count 174
Neutrophil gelatinase-associated lipocalin serum evaluation through normal pregnancy and in pregnancies complicated by preeclampsia. 169
Cold pressor test stimulates the mobilization of endothelial progenitor cells in hypertensive and uremic patients 168
Effect of immunoglobulin treatment on endothelial progenitor cells in systemic lupus erythematosus 168
The erythropoietin and regenerative medicine: a lesson from fish 168
Circulating endothelial progenitor cell mobilization in centenarians: a powerful source for extended renal life. 167
A case-by-case protocol of membranous nephropathy treatment with endovenous infusion of high doses of human immunoglobulins 166
Relaxin: New Pathophysiological Aspects and Pharmacological Perspectives for an Old Protein. 166
Arrhythmias and hemodialysis: role of potassium and new diagnostic tools. 165
Aquaretic agents: What's beyond the treatment of hyponatremia? 162
Circulating progenitor cells after cold pressor test in hypertensive and uremic patients 156
Antiproteinuric effect of DPP-IV inhibitors in diabetic and non-diabetic kidney diseases 153
Aquaretic-induced apoptosis: a cure or a curse? 152
Erythropoietin and its lost receptor [8] 151
Therapy with vasopressin receptor antagonists: the aquaretics 150
Neurobiological model and quality of life in discovering personality of the uremic patient. 149
Xanthine oxidase inhibitors for improving renal function in chronic kidney disease patients: An updated systematic review and meta-analysis 149
Malnutrition in the elderly patient on dialysis. 148
Renal complications in oncohematologic patients. 146
Regenerative medicine: does Erythropoietin have a role? 146
Neutrophil Gelatinase-Associated Lipocalin (NGAL) and progression of chronic kidney disease. 142
Genomic damage in endothelial progenitor cells from uremic patients in hemodialysis 142
Neutrophil gelatinase-associated lipocalin (NGAL) in human neoplasias: a new protein enters the scene. 142
Urinary neutrophil gelatinase-associated lipocalin (uNGAL) levels in patients with Crohn’s disease undergoing treatment with infliximab. 141
Pregnancy in uremic patients: An eventful journey 140
Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage 140
Neutrophilgelatinase-associatedlipocalin(NGAL); un biomarker oltre i confini della nefrologia 140
Neutrophil gelatinase-associated lipocalin as an early biomarker of nephropathy in diabetic patients. 139
Neutrophil gelatinase-associated lipocalin (NGAL): a new piece of the anemia puzzle? 133
RAS inhibition modulates kynurenine levels in a CKD population with and without type 2 diabetes mellitus 133
Erythropoietin and cancer: an old risk. 131
Neutrophil gelatinase-associated lipocalin reflects the severity of renal impairment in subjects affected by chronic kidney disease 129
Il Cold Pressor Test stimola la mobilizzazione di cellule staminali ad indirizzo endoteliale nei soggetti ipertesi ed uremici 125
Pathological and prognostic value of urinary neutrophil gelatinase-associated lipocalin in macroproteinuric patients with worsening renal function 122
Experimental therapies in renal replacement: The effect of two different potassium acetate-free biofiltration protocols on striated muscle fibers 121
Neutrophil gelatinase-associated lipocalin (NGAL) reflects iron status in haemodialysis patients 120
Perioperative iloprost and endothelial progenitor cells in uremic patients with severe limb ischemia undergoing peripheral revascularization. 120
Modifications in relaxin's serum levels during acetate-free biofiltration (AFB): only a new biomarker? 118
NGAL is a precocious marker of therapeutic response. 117
From the oxygen to the organ protection: erythropoietin as protagonist in internal medicine 117
Neutrophil gelatinase-associated lipocalin in patients with autosomal-dominant polycystic kidney disease. 110
Obestatin: a new element for mineral metabolism and inflammation in patients on hemodialysis. 109
Exploring the effects of DPP-4 inhibitors on the kidney from the bench to clinical trials 108
Genomic damage in endothelial progenitor cells from uremic patients. 106
Pulmonary hypertension and erythropoietin. 103
Endothelial progenitor cells at the interface of chronic kidney disease: from biology to therapeutic advancement 103
Neutrophil gelatinase-associated lipocalin immunoexpression in renal tumors: correlation with histotype and histological grade. 97
Parathyroid hormone and mobilization of circulating bone marrow-derived cells in uremic patients. 95
Parathyroid hormone variability parameters for identifying high turnover osteodystrophy disease in hemodialysis patients: An observational retrospective cohort study 95
From kidney to cardiovascular diseases: NGAL as a biomarker beyond the confines of nephrology. 92
Endothelial progenitor cells: pathogenetic role and therapeutic perspectives 89
Neutrophil gelatinase-associated lipocalin levels in chronic haemodialysis patients. 83
Osteoprotegerin and carotid atherosclerosis in dialysis patients: An imaging (ECO-Doppler) and genic expression study 79
NGAL: a new missing link between inflammation and uremic anemia? 77
Renal Concerns in the Treatment of Chronic Hepatitis B with Tenofovir 71
Neutrophil gelatinase-associated lipocalin in the intensive care unit: time to look beyond a single, threshold-based measurement? 67
Neutrophil gelatinase-associated lipocalin levels in patients with crohn disease undergoing treatment with infliximab. 66
Increased plasma neutrophil gelatinase-associated lipocalin levels predict mortality in elderly patients with chronic heart failure. 45
null 39
null 30
null 16
Totale 10.484
Categoria #
all - tutte 34.744
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.744


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022542 0 73 5 19 32 4 26 17 3 120 76 167
2022/20231.563 134 169 75 144 124 152 9 94 609 7 31 15
2023/2024326 31 50 14 32 27 98 2 21 0 14 5 32
2024/20251.543 24 14 53 99 43 62 35 296 393 120 150 254
2025/20264.709 277 334 345 265 388 957 610 608 596 147 84 98
2026/2027556 129 427 0 0 0 0 0 0 0 0 0 0
Totale 10.484